S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
AMEX
Citigroup Fdg (CTH)
Citigroup Fdg (CTH) News

CTH

Citigroup Fdg (CTH)

Citigroup Fdg

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:CTH

1

Date	Time	Source	Headline	Symbol	Company
08/15/2016	5:00AM	GlobeNewswire	Cynapsus Announces Positive Opinion from Data and Safety Monitoring Board on Phase 3 Parkinson's Disease Clinical Study Allow...	AMEX:CTH	Citigroup Fdg
07/18/2016	3:10PM	GlobeNewswire	Cynapsus Therapeutics Announces Positive Phase 3 Dose Titration Phase Results with APL-130277 for the Treatment of OFF Episod...	AMEX:CTH	Citigroup Fdg
06/30/2016	7:00AM	GlobeNewswire	Cynapsus Therapeutics Enrolls Last Patient in Pivotal Phase 3 Efficacy Trial of APL-130277 to Treat OFF Episodes in Patients ...	AMEX:CTH	Citigroup Fdg
05/30/2016	1:00AM	GlobeNewswire	Cynapsus Therapeutics Announces Data Presentations at the European Academy of Neurology Annual Meeting	AMEX:CTH	Citigroup Fdg
04/15/2016	5:00AM	GlobeNewswire	Cynapsus Therapeutics Announces Data Presentations at the American Academy of Neurology Annual Meeting	AMEX:CTH	Citigroup Fdg
12/08/2015	1:00AM	GlobeNewswire	Cynapsus Therapeutics Announces Positive Data Presentations at World Congress on Parkinson's Disease and Related Disorders Me...	AMEX:CTH	Citigroup Fdg
07/17/2014	3:15PM	GlobeNewswire	Cynapsus Therapeutics Inc : Cynapsus Therapeutics Commences Phase 2 Clinical Trials in the United States	AMEX:CTH	Citigroup Fdg
07/08/2014	12:00AM	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Therapeutics Awarded Second Grant from The Michael J. Fox Foundation for Parkinson's Re...	AMEX:CTH	Citigroup Fdg
05/14/2014	5:00AM	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Announces No Buccal Mucosal Irritation in FDA Registration Study of APL-130277 for Park...	AMEX:CTH	Citigroup Fdg
04/24/2014	5:00AM	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Announces Positive Results of CTH-104 Clinical Study of APL-130277 for Parkinson's Dise...	AMEX:CTH	Citigroup Fdg
03/28/2014	5:00AM	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Announces Interim Summary Results of Human Healthy Volunteer Single 25mg Study for APL-...	AMEX:CTH	Citigroup Fdg
01/13/2014	5:00AM	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Announces Completion of Human Healthy Volunteer Crossover Study Results for APL-130277	AMEX:CTH	Citigroup Fdg
05/15/2013	12:00AM	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Therapeutics Publishes White Paper on Apomorphine for 'Off' Periods in Parkinson's Dise...	AMEX:CTH	Citigroup Fdg
03/24/2006	10:00AM	PR Newswire (US)	American Stock Exchange Lists Citigroup Funding Inc.'s 7.5% Sequins Linked to UnitedHealth Group Inc.	TSXV:CTH

Showing the most relevant articles for your search:AMEX:CTH

1

ProText Mobility (PK)

Emergent Health (PK)

Music Licensing (PK)

NaturalShrimp (QB)

Ecare Solutions (PK)

Ronn Motor (PK)

Brookmount Explorations (PK)

Yuenglings Ice Cream (PK)

Innovation Pharmaceuticals (CE)

Clean Vision (QB)

Elite Pharmaceuticals (QB)

Globestar Therapeutics (PK)

Anavex Life Sciences

ERHC Energy (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions